Biotech Values

[floblu14]

MNTA European Patent Applications Update for RMF - Plus MNTA Overview of their Patent Estate -

1. METHODS AND PRODUCTS RELATED TO THE IMPROVED ANALYSIS OF CARBOHYDRATES 2010-06-10

Abstract: The invention relates, in part, to the improved analysis of carbohydrates. In particular, the invention relates to the analysis of carbohydrates, such as N-glycans and O-glycans found on proteins and saccharides attached to lipids. Improved methods, therefore, for the study of glycosylation patterns on cells, tissue and body fluids are also provided. Information from the analysis of glycans, such as the glycosylation patterns on cells, tissues and in body fluids, can be used in diagnostic and treatment methods as well as for facilitating the study of the effects of glycosylation/altered glycosylation. Such methods are also provided. Methods are further provided to assess production processes, to assess the purity of samples containing glycoconjugates, and to select glycoconjugates with the desired glycosylation.

http://v3.espacenet.com/publicationDetails/biblio?DB=EPODOC&adjacent=true&locale=en_V3&FT=D&date=20100610&CC=US&NR=2010144553A1&KC=A1


2. MS METHODS TO EVALUATE GLYCANS
Inventor: BOSQUES CARLOS J [US] ; WASHBURN NATHANIEL J [US] ) Applicant: MOMENTA PHARMACEUTICALS INC [US]

Publication info: 2010-06-03

Abstract - The present disclosure provides, among other things, methods for the identification of sulfated glycans in a mixture of glycans


3. IMPROVED PROCESS FOR THE PREPARATION OF COPOLYMER-1
Inventor: IYER MANI [US] ; BAUER CORINNE [US] (+1) Applicant: MOMENTA PHARMACEUTICALS INC [US]
EC: C07K14/00B; C08G69/10 IPC: C07K14/00; C08G69/10; C07K14/00; (+1)
Publication info: AT452140 (T) - 2010-01-15
Priority Date: 2006-07-05

4. COPOLYMER ASSAY
Inventor: ALESSANDRO JOSEPHINE S D ; HEALY AILEEN (+1) Applicant: MOMENTA PHARMACEUTICALS INC
EC: C07K14/00B; G01N33/50D2 IPC: C07K14/00; G01N33/50; C07K14/00; (+1)
Publication info: AU2008265692 (A1) - 2008-12-24
Priority Date: 2007-06-21

5. SACCHARIDE STRUCTURES AND METHODS OF MAKING AND USING SUCH STRUCTURES
Inventor: ROY SUCHARITA [US] ; KISHIMOTO TAKASHI KEI [US] (+1) Applicant: MOMENTA PHARMACEUTICALS INC [US] ; ROY SUCHARITA [US] (+2)
EC: IPC: C12N9/10; C12N9/10
Publication info: WO2009155108 (A1) - 2009-12-23
Priority Date: 2008-05-30

6. DEFINED GLYCOPROTEIN PRODUCTS AND RELATED METHODS
Inventor: VENKATARAMAN GANESH [US] ; COLLINS BRIAN EDWARD [US] (+6) Applicant: MOMENTA PHARMACEUTICALS INC [US]
EC: G06F19/00C9 IPC: G06F19/00; G06F19/00
Publication info: EP2137655 (A1) - 2009-12-30
Priority Date: 2007-04-16

7. MULTI-DIMENSIONAL CHROMATOGRAPHIC METHODS FOR SEPARATING N-GLYCANS
Inventor: PARSONS IAN CHRISTOPHER [US] ; ZHENG TING [US] (+2) Applicant: MOMENTA PHARMACEUTICALS INC [US]
EC: B01D15/18T; C07K1/36; (+1) IPC: B01D15/18; C07K1/18; G01N30/46; (+3)
Publication info: EP2136896 (A1) - 2009-12-30
Priority Date: 2007-04-16

8. METHODS RELATED TO CELL SURFACE GLYCOSYLATION
Inventor: COLLINS BRIAN EDWARD [US] ; BOSQUES CARLOS J [US] (+7) Applicant: MOMENTA PHARMACEUTICALS INC [US]
EC: G01N33/53F IPC: G01N33/53; G01N33/53
Publication info: EP2135081 (A1) - 2009-12-23
Priority Date: 2007-04-16

9. CHARACTERIZATION OF N-GLYCANS USING EXOGLYCOSIDASES
Inventor: PARSONS IAN CHRISTOPHER [US] ; BULIK DOROTA A [US] (+3) Applicant: MOMENTA PHARMACEUTICALS INC [US]
EC: G06F1/20; F28D15/02M; (+4) IPC: G01N33/68; G01N33/68
Publication info: EP2135094 (A2) - 2009-12-23
Priority Date: 2007-04-16

10. ANALYSIS OF PHOSPHORYLATED GLYCANS, GLYCOPEPTIDES OR GLYCOPROTEINS BY IMAC
Inventor: BOSQUES CARLOS J [US] ; THIRUNEELAKANTAPILLAI LAKSHMANAN [US] (+1) Applicant: MOMENTA PHARMACEUTICALS INC [US]
EC: G01N33/68A8 IPC: G01N33/68; G01N33/68
Publication info: EP2135093 (A1) - 2009-12-23
Priority Date: 2007-04-16

http://v3.espacenet.com/searchResults?locale=en_V3&query=(txt+%3D+momenta)+and+(txt+%3D+pharmaceuticals)&compact=false&DB=EPODOC&submitted=true

_______________________________________________

PATENTS

Over 100 patents give Momenta a strong proprietary position
Momenta possesses a strong intellectual property position around our characterization platform. We license or own a total of over 100 patents and patent applications. Our patent portfolio includes claims covering:

•methods and technologies for characterizing sugars;
•the use of certain enzymes and reagents that specifically recognize polysaccharides in the characterization of sugars;
•methods and technologies for chemical and metabolic synthesis of sugars;
•the composition of matter of certain novel low-molecular-weight herapins (LMWHs), including M118, and heparinase variants;
•methods to produce and identify sugars associated with glycoproteins;
•methods to analyze and monitor glycoprotein profiles for purposes associated with the diagnosis, staging, prognosis and monitoring of cancer; and
•methods for the in vivo non-invasive delivery of sugars.
We also rely on trade secrets, know-how, continuing technological innovation and in-licensing opportunities to develop and maintain our proprietary position

http://www.momentapharma.com/technology/patents.html